Advocates for Orange County’s immigrant population have advice for those concerned about imminent deportation and are ready to help when possible. The OC Rapid Response Network, a mutual aid group ...

In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

The last of the first round of Masters 2025 ties takes place today at Alexandra Palace, as Kyren Wilson faces Zhang Anda and ...

for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Gel, 0.38%. Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post ...

We still encourage you to apply online if possible. If you need to apply on paper, use a courier to send us your application more quickly.

The Immigration, Refugees and Citizenship Canada (IRCC) said that in 2025, it will only process family sponsorship applications that were submitted in 2024 under the Parents and Grandparents Program.

Though the Jets have already started their interviews with general manager and head-coach candidates, the search process will kick into higher gear this week. Here is a primer on some of the rules ...

This initiative, which began two years ago, represents a significant transition from traditional paperwork to a streamlined digital process across all 167 visa sections of German missions worldwide.

Fourteen people were killed in the New Year's Day attack on Bourbon Street. Authorities investigating the suspect in the truck attack that killed 14 and injured dozens in New Orleans on New Year's ...

Scheduled for February 16, 2025, the written examination is a critical part of the selection process. This objective test will evaluate candidates' aptitude, knowledge, and overall understanding of ...

Taletrectinib's NDA is based on phase 2 TRUST-I and TRUST-II trials, showing significant efficacy in ROS1-positive NSCLC. The trials reported tumor shrinkage in 89% of TKI-naive and 56% of ...